Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Biotech-beach entities : Eli lilly and company save search
Blacksmith Medicines To Highlight Preclinical Oncology Data Demonstrating a Potent and Selective FEN1 Inhibitor Has Synergy with Multiple DDR Drug Classes at AACR Annual Meeting 2024
Published: 2024-04-10 (Crawled : 22:00) - biospace.com/
LLY | $745.04 -0.76% 730K
|
Health Technology
|
| O: -0.71%
H: 0.0%
C: 0.0%
drug preclinical meeting
Blacksmith Medicines to Present at the 23rd Annual Needham Healthcare Conference
Published: 2024-04-03 (Crawled : 15:00) - biospace.com/
LLY | $745.04 -0.76% 730K
|
Health Technology
|
| O: 0.76%
H: 0.0%
C: 0.0%
conference
Gallant Therapeutics Adds Animal Health Executive Aaron Schacht to Board of Directors
Published: 2024-02-06 (Crawled : 15:00) - biospace.com/
LLY | $745.04 -0.76% 730K
|
Health Technology
|
| O: 5.07%
H: 0.0%
C: -4.98%
health animal therapeutics
Cardiff Oncology Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update
Published: 2023-03-02 (Crawled : 22:00) - biospace.com/
LLY | $745.04 -0.76% 730K
|
Health Technology
|
| O: -0.76%
H: 1.45%
C: 1.05%
CRDF | $5.02 -4.92% 470K
|
Health Services
|
| O: 0.58%
H: 1.16%
C: 0.0%
year update results
DermTech Appoints Two New Board Members
Published: 2022-07-18 (Crawled : 00:00) - biospace.com/
LLY | $745.04 -0.76% 730K
|
Health Technology
|
| O: -0.45%
H: 0.56%
C: -2.53%
NSTG | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: 0.88%
H: 1.91%
C: -7.96%
ILMN | $117.87 -2.72% 630K
|
Health Technology
|
| O: 0.71%
H: 2.62%
C: -1.71%
DMTK 4 | $0.609 -1.77% 32K
|
Health Technology
|
| O: 3.96%
H: 5.49%
C: -3.66%
ABCM | $23.99 0.0% 7.4M
|
Health Technology
|
| O: 0.44%
H: 1.23%
C: -2.69%
Avidity Biosciences Reports First Quarter 2022 Financial Results and Recent Highlights
Published: 2022-05-10 (Crawled : 22:00) - biospace.com/
LLY | $745.04 -0.76% 730K
|
Health Technology
|
| O: 0.93%
H: 0.0%
C: 0.0%
RNA | $23.72 -0.8% 170K
|
Health Technology
|
| O: 5.75%
H: 1.46%
C: -6.51%
results
Erasca Announces Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company to Evaluate ERAS-007 and Cetuximab Combination
Published: 2022-03-10 (Crawled : 23:00) - biospace.com/
ERAS | $1.965 -1.75% 170K
|
|
| O: -1.75%
H: 6.29%
C: -0.43%
LLY | $745.04 -0.76% 730K
|
Health Technology
|
| O: 0.02%
H: 1.86%
C: 1.21%
eras-007 ces trial collaboration
Avidity Biosciences Reports Fourth Quarter and Year-End 2021 Financial Results and Recent Highlights
Published: 2022-03-01 (Crawled : 22:00) - biospace.com/
LLY | $745.04 -0.76% 730K
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
RNA | $23.72 -0.8% 170K
|
Health Technology
|
| O: 0.0%
H: 1.42%
C: -3.6%
financial results report bioscience results
Cardiff Oncology Reports Fourth Quarter and Full Year 2021 Results and Recent Highlights
Published: 2022-02-24 (Crawled : 00:00) - biospace.com/
LLY | $745.04 -0.76% 730K
|
Health Technology
|
| O: -1.4%
H: 0.0%
C: 0.0%
CRDF | $5.02 -4.92% 470K
|
Health Services
|
| O: -5.22%
H: 0.0%
C: 0.0%
report results
Bluestar Genomics Appoints David Mullarkey Chief Executive Officer
Published: 2022-01-10 (Crawled : 13:30) - biospace.com/
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 1.28%
H: 0.0%
C: 0.0%
LLY | $745.04 -0.76% 730K
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: 0.0%
Artiva Biotherapeutics Strengthens Leadership Team with the Appointment of Christopher Horan as Chief Technical Operations Officer
Published: 2022-01-04 (Crawled : 15:00) - biospace.com/
LLY | $745.04 -0.76% 730K
|
Health Technology
|
| O: -1.79%
H: 0.0%
C: 0.0%
therapeutics iot
DTx Pharma to Present at Upcoming Investor Conferences
Published: 2021-09-16 (Crawled : 12:00) - biospace.com/
LLY | $745.04 -0.76% 730K
|
Health Technology
|
| O: 0.15%
H: 0.26%
C: -1.3%
conference presentation pharma
Mirati Therapeutics Reports Second Quarter 2021 Financial Results and Recent Corporate Updates
Published: 2021-08-05 (Crawled : 22:00) - biospace.com/
LLY | $745.04 -0.76% 730K
|
Health Technology
|
| O: 0.31%
H: 0.85%
C: 0.35%
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: -0.46%
H: 5.72%
C: 4.57%
financial results results
DTx Pharma to Participate in Upcoming Virtual Investor Conferences
Published: 2021-05-26 (Crawled : 13:00) - biospace.com/
LLY | $745.04 -0.76% 730K
|
Health Technology
|
| O: 0.01%
H: 1.61%
C: 0.88%
conference pharma
Avidity Biosciences Reports First Quarter 2021 Financial Results and Recent Highlights
Published: 2021-05-12 (Crawled : 22:00) - biospace.com/
LLY | $745.04 -0.76% 730K
|
Health Technology
|
| O: 0.0%
H: 0.46%
C: -0.8%
RNA | $23.72 -0.8% 170K
|
Health Technology
|
| O: -1.87%
H: 9.36%
C: 5.86%
financial results results bioscience
Q1 2021: A Look at Biopharma’s Top 25 Companies by Market Cap
Published: 2021-05-03 (Crawled : 17:00) - biospace.com/
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 0.53%
H: 1.05%
C: 0.98%
LLY | $745.04 -0.76% 730K
|
Health Technology
|
| O: 0.12%
H: 1.84%
C: 1.6%
SNY | $46.2 0.59% 210K
|
Health Technology
|
| O: -4.18%
H: 1.62%
C: 1.41%
REGN | $895.56 -0.33% 120K
|
Health Technology
|
| O: 0.46%
H: 1.69%
C: 1.06%
MRNA S | $105.27 1.36% 460K
|
Health Technology
|
| O: 2.84%
H: 2.77%
C: 1.15%
biopharma
DTx Pharma to Participate in the 2021 Needham Virtual Healthcare Conference
Published: 2021-04-07 (Crawled : 14:15) - biospace.com/
LLY | $745.04 -0.76% 730K
|
Health Technology
|
| O: 0.05%
H: 0.15%
C: -0.32%
conference needham virtual healthcare conference pharma
Gainers vs Losers
| 49% | 51% |
Top 10 Gainers
TPET | $0.503 117.66% 21M
|
n/a
WISA 4 | $3.22 84.0% 56M
|
Electronic Technology
SXTC | $2.56 82.86% 11M
|
Health Technology
PALI | $6.57 57.93% 19M
|
Manufacturing
JAGX | $0.1767 48.74% 430M
|
Health Technology
DYNT | $0.5255 41.87% 18M
|
Health Technology
PRSO | $1.79 40.95% 38M
|
Manufacturing
MCBC | $13.795 38.92% 820K
|
Finance
BTTR | $6.86 34.51% 5.2M
|
Manufacturing
SNGX | $0.51 32.09% 6.3M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.